Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence-Reference-Cited by-同舟云学术

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

Published:2016-03-07 Issue:5 Volume:63 Page:1493-1505
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Poordad Fred¹,Schiff Eugene R.²,Vierling John M.³,Landis Charles⁴,Fontana Robert J.⁵,Yang Rong⁶,McPhee Fiona⁷,Hughes Eric A.⁶,Noviello Stephanie⁶,Swenson Eugene S.⁷

Affiliation:

1. The Texas Liver InstituteUniversity of Texas Health Science CenterSan Antonio TX

2. Schiff Center for Liver DiseasesUniversity of Miami Miller School of MedicineMiami FL

3. Division of Abdominal TransplantationBaylor College of MedicineHouston TX

4. Division of Gastroenterology and Hepatology, Department of MedicineUniversity of WashingtonSeattle WA

5. University Division of Gastroenterology, Department of Internal MedicineUniversity of Michigan Medical CenterAnn Arbor MI

6. Bristol‐Myers SquibbLawrence Township NJ

7. Discovery VirologyBristol‐Myers Squibb Research and DevelopmentWallingford CT

Funder

Bristol-Myers Squibb.

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28446

Reference29 articles.

1. World Health Organization.Guidelines for the screening care and treatment of persons with hepatitis C infection.http://www.who.int/hiv/pub/hepatitis/hepatitis‐c‐guidelines/en/. Accessed August 3 2015.

2. The global burden of hepatitis C

3. Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

4. OPTN/SRTR 2012 Annual Data Report: Liver

5. Post-liver transplant cholestatic hepatitis C: A systematic review of clinical and pathological findings and application of consensus criteria

Cited by 386 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

2. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

3. Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients;Viruses;2023-08-07

4. Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response;Journal of the Chinese Medical Association;2023-07-19

5. Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence;Biomedicines;2023-06-26